Together, these data suggest BDP1 is not prognostic in serous ovarian cancer; however, the data presented in Figure 1 suggests that BDP1 alterations in serous ovarian cancer warrant further investigation. Here, BDP1 is linked to ovarian serous adenocarcinoma.